Chronic lymphocytic leukemia (CLL) Clinical Trials in Rochester, NY
As of July 2026, 3 paid clinical trials are recruiting for Chronic lymphocytic leukemia (CLL) in Rochester, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Rochester
Filter results
3 clinical trials for Chronic lymphocytic leukemia (CLL)
·Clear filters·↓ Download CSVTesting the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Top Research Study Locations in Rochester
Researchers run research studies in Rochester, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Rochester | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Malignant Solid Neoplasm | 163 |
| University of Rochester Medical Center | Healthy, Pulmonary Hypertension, Breathing | 104 |
| Rochester Clinical Research, LLC | Obesity, Overweight, Chronic Pain | 13 |
| Highland Hospital | Stage IVA Prostate Cancer AJCC v8, Abscess, Advanced Colorectal Carcinoma | 12 |
| Rochester General Hospital | Aortic Valve Stenosis, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | 10 |
| Pluta Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 7 |
| Wilmot Cancer Institute | Breast Cancer, Acute Leukemia, Aplastic Anemia | 7 |
| Rochester Clinical Research | Acute Migraine, Atherosclerotic Cardiovascular Disease, Crohn's Disease | 6 |
| University of Rochester Medical Center (URMC) | Adult Acute Myeloid Leukemia, Hpv, Phenylketonuria | 5 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Irritable Bowel Syndrome, Tumours, Gynecological | 4 |
| Strong Memorial Hospital | Aortic Stenosis, Atrial Fibrillation, Cardiotoxicity | 4 |
| Wilmot Cancer Institute Radiation Oncology at Greece | Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Pancreatic Adenocarcinoma | 4 |
| Unity Park Ridge Campus | Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma | 3 |
| University of Rochester Medical Center Strong Memorial | Cystic Fibrosis, Cystic Fibrosis (CF) | 3 |
| University of Rochester Wilmot Cancer Institute | Angiosarcoma, Breast Cancer, Breast Neoplasms | 3 |
| AD-CARE, University of Rochester Medical Center | Alzheimers Disease | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| American Thrombosis and Hemostasis Network | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 2 |
| Chester F. Carlson Center for Imaging Science | Distance Viewing, L- and M-cone Modulation Only, L- and S-cone Modulation Only | 2 |
| Gastroenterology Group Of Rochester, LLP | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Mayo Clinic | Lymphedema, Breast Cancer, Solid and Hematological Malignancies | 2 |
| Mt. Hope Family Center | Fetal Alcohol Spectrum Disorders, Posttraumatic Stress Disorder | 2 |
| Retina Associates of Western NY, P.C. | Epiretinal Membrane, Proliferative Diabetic Retinopathy (PDR) | 2 |
| Retina Associates of Western New York | Age Related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 2 |
| Rochester Clinical Research, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
Active & Upcoming Studies in Rochester (2026)
Recruiting trials in Rochester grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (171 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates · Phase 2 · University of Colorado, Denver
Neurology & pain (31 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Cardiovascular (22 active studies)
- The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease · University of Rochester
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study · Phase 3 · YS Life Science Co., Ltd.
Diabetes & metabolic (17 active studies)
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity · Phase 3 · Pfizer
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
Mental health & behavior (11 active studies)
- Deaf CBT-TS to Reduce Suicide Risk · University of Rochester
- Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression · Phase 2 · University of Rochester
Eye & vision (9 active studies)
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study · Phase 3 · YS Life Science Co., Ltd.
- BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber · University of Rochester
Pediatric (6 active studies)
- Tumor-Lymph Node Mapping · University of Rochester
- Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD) · University of Rochester
HIV / STI (2 active studies)
- Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
- A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (1 active study)
- SAVE: School Ambassadors for Vaccine Education · University of Rochester
Common conditions studied in Rochester
- Acute Myeloid Leukemia (11 active studies)
- Breast Cancer (10 active studies)
- Obesity (8 active studies)
- Cancer (6 active studies)
- Heart Failure (6 active studies)
- Overweight (6 active studies)
Leading research sponsors in Rochester
- University of Rochester
- National Cancer Institute (NCI)
- Eli Lilly and Company
- SWOG Cancer Research Network
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Rochester?
There are approximately 457 recruiting clinical trials in Rochester, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rochester pay participants?
Most recruiting trials in Rochester compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rochester?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rochester?
The most common conditions under active study in Rochester include Acute Myeloid Leukemia (11), Breast Cancer (10), Obesity (8), Cancer (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rochester?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rochester on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rochester?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rochester?
Recruiting research sites in Rochester include University of Rochester, University of Rochester Medical Center, Rochester Clinical Research, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rochester right now?
The largest active categories in Rochester are Cancer & tumors (171), Neurology & pain (31), Cardiovascular (22). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.